(Total Views: 250)
Posted On: 03/21/2017 11:00:09 AM
Post# of 23071
PTIE meeting was very positive, leaving a lot of excitement for this year's growth
Anticipating about 15% growth between here and the end of the year, while they finish their trials. Since they were preapproved for priority processing by the FDA, I would not be surprised if there's Remoxy approval by this time in 2018...
If they are successful with their tests (which, seems to me like the tests are going to be a breeze!) - then FDA approval is a great way to really boost your share price
They aren't going to market it themselves - which is also good news... They're a tech company, not a marketing company -- lowers their ability for profits, but makes it a lot easier to be profitable and focus on some of their other products....
Definitely happy with my unrealized gains right now, just not sure if I'll hold onto it beyond the FDA approval announcement or not -- I can't be too greedy
Anticipating about 15% growth between here and the end of the year, while they finish their trials. Since they were preapproved for priority processing by the FDA, I would not be surprised if there's Remoxy approval by this time in 2018...
If they are successful with their tests (which, seems to me like the tests are going to be a breeze!) - then FDA approval is a great way to really boost your share price
They aren't going to market it themselves - which is also good news... They're a tech company, not a marketing company -- lowers their ability for profits, but makes it a lot easier to be profitable and focus on some of their other products....
Definitely happy with my unrealized gains right now, just not sure if I'll hold onto it beyond the FDA approval announcement or not -- I can't be too greedy
(1)
(0)
